While the FDA has approved over 20 different categories of contraceptives, only two are available for men to prevent ...

today announced several new governance and key clinical leadership appointments. Felix J. Baker, Ph.D., will succeed Pierre Legault, BAA, MBA, CPA, CA, as chairman of the Bicycle Therapeutics ...

The University of Minnesota College of Pharmacy released research Wednesday that lays the groundwork for the first hormone-free male birth control pill to enter clinical trials. Currently, people with ...

A groundbreaking male birth control pill, YCT529, is being developed by researchers at the University of Minnesota in ...

vTv Therapeutics, a biopharmaceutical company based in High Point, has received clearance from the U.S. Food and Drug ...

He holds a Bachelor of Science in Pharmacy from the University of Connecticut and is a registered pharmacist. Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment ...

Arcturus Therapeutics, based in San Diego, has proprietary enabling technologies: (i) LUNAR lipid-mediated delivery, (ii) self-transcribing and replicating mRNA (STARR) technology, and (iii ...

To advance the profession of pharmacy, foster an environment that values employee contributions, and support development through balance and accountability. To have fun, recognize our accomplishments, ...

Located on Fred Hutchinson Cancer Center's South Lake Union campus in Seattle, the COVID-19 Clinical Research Center opened in October 2020 as a new resource for clinical research advancement and ...

Outlook Therapeutics, Inc. has announced the participation of Dr. Jennifer Kissner, Senior Vice President of Clinical Development, in a Virtual Investor segment discussing the 12-week safety and ...

We are thrilled to welcome Michael to Avalo’s Board of Directors during this pivotal time in our Company’s growth,” said Dr. Garry Neil, CEO of Avalo Therapeutics. “Michael’s extensive experience in ...